HomeMANORAMA › Filing
🔔 Get instant alerts when MANORAMA files quarterly results on BSE Start free trial →

Investor Presentation with respect to Unaudited Financial Results for the Quarter ended June 30, 2026.

Filed: 13 Aug 2026, 19:20 IST Exchange: BSE Category: Financial Results — Audited Results
FY26 results: Standalone: Revenue 13.577bn +77.9% y-y (7.708bn) EBITDA 3.677bn +92.4% y-y (1.911bn) EBITDA margin 27.1% (24.8%) +230 bps y-y PAT 2.332bn +107.8% y-y (1.121bn) Consolidated: Revenue 13.667bn +77.3% y-y (7.708bn) EBITDA 3.613bn +87.6% y-y (1.926bn estimated from standalone) EBITDA margin 26.4% (24.8%) +160 bps y-y PAT 2.249bn +100.7% y-y (1.121bn) Dividend: Not stated Commentary: The company reported strong revenue and profitability growth in FY26 driven by capacity expansion, improved product mix, and operational leverage. Strategic investments in sourcing and manufacturing capacity underpin long-term growth prospects.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 MANORAMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add MANORAMA to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Manorama Industries Limited

Important. The summary above is generated automatically from Manorama Industries Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.